Production of pH-responsive microparticles by spray drying: investigation of experimental parameter effects on morphological and release properties.
During spray drying, emphasis is placed on process optimisation to generate favourable particle morphological and flow properties. The effect of the initial feed solution composition on the drug release from the prepared microparticles (MPs) is rarely considered. We investigated the effects of solvent composition, feed solution concentration and drug-loading on sodium salicylate, hydrocortisone and triamcinolone release from spray-dried Eudragit L100 MPs. Eudragit L100 is a pH-responsive polymer whose dissolution threshold is pH 6 so dissolution testing of the prepared MPs at pH 5 and 1.2 illustrated non-polymer controlled burst release. Increasing the water content of the initial ethanolic feed solution significantly reduced hydrocortisone burst release at pH 5, as did reducing the feed solution concentration. These findings caution that changes in feed solution concentration or solvent composition not only affect particles' morphological characteristics but can also negatively alter their drug release properties. This work also illustrate that drug-free MPs can have different morphological properties to drug-loaded MPs. Therefore, process optimisation needs to be carried out using drug-loaded systems. Depending on the physicochemical properties of the encapsulated active pharmaceutical ingredient (API), drug-loading can affect the polymer solubility in the initial feed solution with consequent impact on MPs morphological and release properties.
Rizi
Khalida
K
Reading School of Pharmacy, University of Reading, Whiteknights, Reading, UK.
Green
Rebecca J
RJ
Donaldson
Michael
M
Williams
Adrian C
AC
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D003692:Delayed-Action Preparations / Q000737:chemistry*; D003890:Desiccation; D006854:Hydrocortisone / Q000008:administration & dosage*; D006863:Hydrogen-Ion Concentration; D008863:Microspheres; D011109:Polymethacrylic Acids / Q000737:chemistry*; D012980:Sodium Salicylate / Q000008:administration & dosage*; D012995:Solubility; D012997:Solvents / Q000737:chemistry; D014221:Triamcinolone / Q000008:administration & dosage*
D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D011109:Polymethacrylic Acids; D012997:Solvents; D014221:Triamcinolone; C038300:methylmethacrylate-methacrylic acid copolymer; D006854:Hydrocortisone; D012980:Sodium Salicylate